• 9 Oct 2025

Dr Jérôme Théobald

After obtaining his PhD in Physical Chemistry, Jérôme began his career as a Process Development Engineer, and then moved on to Engineering and Production Manager at Novasep. He then advanced to Director of Sales and Marketing to enable him to be closer to the customer needs, before he moved on to Director of Strategic Business Development, where he was integral in the acceleration of the company. Since then, he has held positions as CEO and COO for a number of life science companies, ahead of being appointed as CatSci’s new Chief Operating Officer.

Jérôme brings with him almost 30 years’ experience in the pharmaceutical market. By harnessing CatSci’s talent, culture, capabilities and offerings, Jerome is responsible for ensuring that our internal operations run seamlessly. In 2025, Jérôme became Director of European Business. This will enable us to continue offering more and better to our global customers to meet their evolving needs.

Resources & Insights

  • 11 Nov 2025
From Sequence to Success: Accelerating Oligonucleotide Discovery
  • Bioscience
  • Design Make Test Analyse
  • Oligonucleotides
  • Case Studies
1 MB
  • 14 Oct 2025
CatSci Announces Strategic Collaboration with BRAINBiocatalysts to Advance Biocatalysis and Complex Synthetic Medicines
  • News
  • 6 Oct 2025
Advances in Small Molecule Drug Development 2025
  • Events
  • 20 Aug 2025
Peptide Oligonucleotide Conjugates – Why the Excitement?
  • Blog